Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,739,587
+$644,960 QoQ
Shares Held
6,913
+37.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,078
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $86,175,801 across 12 Drug Manufacturers - General names. ABBV ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
72,203 | $26,146,150 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
161,528 | $20,407,447 | |
| 3 | LLY |
ELI LILLY & Co
|
9,068 | $10,876,432 | |
| 4 | NVS |
Novartis AG
|
49,000 | $7,679,280 | |
| 5 | JNJ |
Johnson & Johnson
|
28,214 | $7,165,509 | |
| 6 | BIIB |
Biogen Inc.
|
23,497 | $5,076,761 | |
| 7 | MRK |
Merck & Co., Inc.
|
29,663 | $3,811,695 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
6,913 | $1,739,587 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,739,587 | 6,913 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,094,627 | 5,033 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,623,649 | 7,106 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,525,175 | 10,906 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,976,787 | 16,037 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $3,489,136 | 16,653 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,767,855 | 15,576 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,253,010 | 6,345 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $470,307 | 2,742 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $645,544 | 3,545 | Shares | Sole | 2024-05-21 | |
| No filing history on record for this holder in this stock. | ||||||